These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15574571)

  • 1. Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis.
    Zivadinov R; Grop A; Sharma J; Bratina A; Tjoa CW; Dwyer M; Zorzon M
    J Neuroimaging; 2005 Jan; 15(1):27-36. PubMed ID: 15574571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term brain atrophy changes in relapsing-remitting multiple sclerosis.
    Zivadinov R; Bagnato F; Nasuelli D; Bastianello S; Bratina A; Locatelli L; Watts K; Finamore L; Grop A; Dwyer M; Catalan M; Clemenzi A; Millefiorini E; Bakshi R; Zorzon M
    J Neurol Sci; 2004 Aug; 223(2):185-93. PubMed ID: 15337621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.
    Tavazzi E; Dwyer MG; Weinstock-Guttman B; Lema J; Bastianello S; Bergamaschi R; Cosi V; Benedict RH; Munschauer FE; Zivadinov R
    Neuroimage; 2007 Jul; 36(3):746-54. PubMed ID: 17498974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal study.
    Rudick RA; Lee JC; Simon J; Fisher E
    Ann Neurol; 2006 Aug; 60(2):236-42. PubMed ID: 16786526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.
    Zivadinov R; Locatelli L; Cookfair D; Srinivasaraghavan B; Bertolotto A; Ukmar M; Bratina A; Maggiore C; Bosco A; Grop A; Catalan M; Zorzon M
    Mult Scler; 2007 May; 13(4):490-501. PubMed ID: 17463072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of brain atrophy in subcortical vascular disease: a comparison of different approaches and the impact of ischaemic lesions.
    O'Sullivan M; Jouvent E; Saemann PG; Mangin JF; Viswanathan A; Gschwendtner A; Bracoud L; Pachai C; Chabriat H; Dichgans M
    Neuroimage; 2008 Nov; 43(2):312-20. PubMed ID: 18722537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of MRI coregistration on serial short-term brain volume changes in multiple sclerosis.
    Fritz DA; Dwyer MG; Bagnato F; Watts KL; Bratina A; Zorzon M; Durastanti V; Locatelli L; Millefiorini E; Zivadinov R
    Neurol Res; 2006 Apr; 28(3):275-9. PubMed ID: 16687053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study.
    Frohman EM; Dwyer MG; Frohman T; Cox JL; Salter A; Greenberg BM; Hussein S; Conger A; Calabresi P; Balcer LJ; Zivadinov R
    J Neurol Sci; 2009 Jul; 282(1-2):96-105. PubMed ID: 19439327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary-progressive form of multiple sclerosis: MRI changes versus clinical status.
    Masek M; Vaneckova M; Krasensky J; Danes J; Havrdova E; Hrebikova T; Seidl Z
    Neuro Endocrinol Lett; 2008 Aug; 29(4):461-6. PubMed ID: 18766142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
    Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
    J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of cortical lesions is dependent on choice of slice thickness in patients with multiple sclerosis.
    Dolezal O; Dwyer MG; Horakova D; Havrdova E; Minagar A; Balachandran S; Bergsland N; Seidl Z; Vaneckova M; Fritz D; Krasensky J; Zivadinov R
    Int Rev Neurobiol; 2007; 79():475-89. PubMed ID: 17531855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A semiautomated measure of whole-brain atrophy in multiple sclerosis.
    Bermel RA; Sharma J; Tjoa CW; Puli SR; Bakshi R
    J Neurol Sci; 2003 Apr; 208(1-2):57-65. PubMed ID: 12639726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
    J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.
    Oreja-Guevara C; Charil A; Caputo D; Cavarretta R; Sormani MP; Filippi M
    Arch Neurol; 2006 May; 63(5):736-40. PubMed ID: 16682543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of whole-brain atrophy in multiple sclerosis.
    Pelletier D; Garrison K; Henry R
    J Neuroimaging; 2004 Jul; 14(3 Suppl):11S-19S. PubMed ID: 15228755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agreement between different input image types in brain atrophy measurement in multiple sclerosis using SIENAX and SIENA.
    Neacsu V; Jasperse B; Korteweg T; Knol DL; Valsasina P; Filippi M; Barkhof F; Rovaris M; Vrenken H;
    J Magn Reson Imaging; 2008 Sep; 28(3):559-65. PubMed ID: 18777529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
    Ramasamy DP; Benedict RH; Cox JL; Fritz D; Abdelrahman N; Hussein S; Minagar A; Dwyer MG; Zivadinov R
    J Neurol Sci; 2009 Jul; 282(1-2):47-54. PubMed ID: 19201003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' stratification and correlation of brain magnetic resonance imaging parameters with disability progression in multiple sclerosis.
    Vaneckova M; Seidl Z; Krasensky J; Havrdova E; Horakova D; Dolezal O; Burgetova A; Masek M
    Eur Neurol; 2009; 61(5):278-84. PubMed ID: 19295214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontal parenchymal atrophy measures in multiple sclerosis.
    Locatelli L; Zivadinov R; Grop A; Zorzon M
    Mult Scler; 2004 Oct; 10(5):562-8. PubMed ID: 15471374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.